Back to Authors

Lifrak, Eric T.

A5041341524 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 1

Dehydroepiandrosterone reduces cancellous bone osteopenia in ovariectomized rats

American Journal of Physiology-Endocrinology and Metabolism | December 21, 2017 | Volume: 258 | Issue: 4 | Pages: E673-E677

10.1152/ajpendo.1990.258.4.e673 | PMID 2139760

The effects of dehydroepiandrosterone (DHA) on cortical bone at the tibial diaphysis and cancellous bone at the tibial metaphysis were determined in intact and ovariectomized rats. Total plasma DHA was reduced at 10 and 16 wk after ovariectomy. Intact and ovariectomized rats were implanted monthly with controlled-release subcutaneous pellets containing 2.5 mg of DHA or placebo. Plasma DHA was elevated in DHA-treated intact rats and was near normal in hormone-treated ovariectomized rats. Ovariectomy resulted in severe cancellous bone osteopenia, which was reduced in DHA-treated animals. Cross-sectional and cortical areas were increased at the diaphysis in ovariectomized rats, and this was not altered by DHA treatment. Bone formation at the endosteal and periosteal surfaces of the tibial diaphysis was decreased 16 wk after ovariectomy, and DHA treatment appeared to antagonize these changes. We interpret these results as evidence that decreased peripheral DHA levels contribute to the skeletal changes in ovariectomized rats.